Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/28867
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOjaimi S.en
dc.contributor.authorPurcell R.en
dc.contributor.authorDoherty R.en
dc.date.accessioned2021-05-14T09:43:38Zen
dc.date.available2021-05-14T09:43:38Zen
dc.date.copyright2020en
dc.date.created20200504en
dc.date.issued2020-05-04en
dc.identifier.citationJournal of Paediatrics and Child Health. 56 (4) (pp 658-659), 2020. Date of Publication: 01 Apr 2020.en
dc.identifier.issn1034-4810en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/28867en
dc.languageenen
dc.publisherBlackwell Publishing (E-mail: info@asia.blackwellpublishing.com)en
dc.relation.ispartofJournal of Paediatrics and Child Healthen
dc.subject.meshhighly active antiretroviral therapy-
dc.subject.meshimmunodeficiency virus infection-
dc.subject.meshhypoxic ischemic encephalopathy/co-
dc.subject.meshinfection-
dc.subject.meshinfection risk-
dc.subject.meshliver toxicity-
dc.subject.meshmixed infection-
dc.subject.meshmonotherapy-
dc.subject.meshnewborn-
dc.subject.meshopportunistic infection/co-
dc.subject.meshpatient attitude-
dc.subject.meshperinatal infection/co-
dc.subject.meshprematurity/co-
dc.subject.meshprotein function-
dc.subject.meshsyphilis-
dc.subject.meshtuberculosis-
dc.subject.meshvirus load-
dc.subject.meshantiretrovirus agent/it [Drug Interaction]-
dc.subject.meshantiretrovirus agent-
dc.subject.meshcytochrome P450-
dc.subject.meshisoniazid-
dc.subject.meshisoniazid/it [Drug Interaction]-
dc.subject.meshlamivudine-
dc.subject.meshnevirapine-
dc.subject.meshnevirapine/it [Drug Interaction]-
dc.subject.meshnevirapine/ig [Intragastric Drug Administration]-
dc.subject.meshrifampicin-
dc.subject.meshrifampicin/it [Drug Interaction]-
dc.subject.meshvirus DNA-
dc.subject.meshvirus RNA-
dc.subject.meshzidovudine/it [Drug Interaction]-
dc.subject.meshzidovudine-
dc.subject.meshAIDS patient-
dc.subject.meshcytomegalovirus infection-
dc.subject.meshdisease transmission-
dc.subject.meshdrug absorption-
dc.subject.meshdrug clearance-
dc.subject.meshdrug dose titration-
dc.subject.meshdrug metabolism-
dc.subject.meshgastrointestinal absorption-
dc.subject.meshgenotype-
dc.subject.meshgestational age-
dc.subject.meshhigh risk patient-
dc.titleLetter to the Editor.en
dc.typeLetteren
dc.identifier.affiliationPaediatric - Infection and Immunity-
dc.type.studyortrialOpinion, perspective or news-
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1111/jpc.14851-
dc.publisher.placeAustraliaen
dc.identifier.pubmedid32307776 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32307776]en
dc.identifier.source2004713066en
dc.identifier.institution(Purcell, Doherty, Ojaimi) Department of Paediatric Infection and Immunity, Monash Children's Hospital, Melbourne, VIC, Australia (Doherty) Department of Paediatrics, Monash University, Melbourne, VIC, Australiaen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2020 Elsevier B.V., All rights reserved.en
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.openairetypeLetter-
crisitem.author.deptInfectious Diseases and Clinical Microbiology-
Appears in Collections:Articles
Show simple item record

Page view(s)

22
checked on Feb 6, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.